Dr. Veerapol Khemarangsan, Chief Executive Officer of Medeze Group Public Company Limited (“MEDEZE”), Mr. Phiphat Phitsanuwongrak, Chief Accounting and Financial Officer of MEDEZE Treasury PTE. LTD., provided insights to securities analysts at the Analyst Meeting Year-End 2024. The company reported total revenue of 897.22 million THB, marking a 25.78% increase, with a net profit of 338.74 million THB for 2024, reflecting a 41.39% growth. MEDEZE continues to expand its biotechnology business in the Philippines through its subsidiary, MEDEZE Treasury PTE. LTD., by investing in the establishment of a Stem Cell Banking Biotechnology facility. This includes state-of-the-art laboratories for analysis, isolation, cultivation, and high-efficiency storage of stem cells to meet the growing demand for stem cell preservation in the Philippines.The event was held at Chatrium Riverside Hotel, Bangkok.
IR Press Releases